RB1CC1 Protein
Overview
RB1CC1 (RB1-Inducible Coiled-Coil 1), also known as FIP200 (FAK-Interacting Protein of 200 kDa) or RB1CC1-FIP200, is a large scaffolding protein encoded by the RB1CC1 gene located on chromosome 8q24.3. The protein consists of approximately 2,017 amino acids and is characterized by multiple coiled-coil domains and a focal adhesion targeting (FAT) domain, which enable its role as a critical regulatory hub in cellular autophagy and protein quality control pathways. RB1CC1 was first identified as a target of the retinoblastoma (RB) tumor suppressor protein and has since emerged as a fundamental component of selective autophagy and stress-responsive signaling cascades relevant to neurodegeneration.
Function/Biology
RB1CC1 functions primarily as a scaffolding protein that orchestrates autophagy initiation through its interactions with the ULK1 complex, a serine/threonine kinase complex essential for autophagosome formation. The protein serves as a binding platform that recruits and assembles core autophagy machinery components, including ULK1, ATG13, and ATG101. Through its multiple protein-protein interaction domains, RB1CC1 mediates the organization of focal adhesion complexes and regulates cell motility in response to metabolic stress. Additionally, RB1CC1 participates in selective autophagy pathways, particularly mitophagy and xenophagy, enabling cells to remove damaged mitochondria and intracellular pathogens through autophagy-dependent mechanisms.
...RB1CC1 Protein
Overview
RB1CC1 (RB1-Inducible Coiled-Coil 1), also known as FIP200 (FAK-Interacting Protein of 200 kDa) or RB1CC1-FIP200, is a large scaffolding protein encoded by the RB1CC1 gene located on chromosome 8q24.3. The protein consists of approximately 2,017 amino acids and is characterized by multiple coiled-coil domains and a focal adhesion targeting (FAT) domain, which enable its role as a critical regulatory hub in cellular autophagy and protein quality control pathways. RB1CC1 was first identified as a target of the retinoblastoma (RB) tumor suppressor protein and has since emerged as a fundamental component of selective autophagy and stress-responsive signaling cascades relevant to neurodegeneration.
Function/Biology
RB1CC1 functions primarily as a scaffolding protein that orchestrates autophagy initiation through its interactions with the ULK1 complex, a serine/threonine kinase complex essential for autophagosome formation. The protein serves as a binding platform that recruits and assembles core autophagy machinery components, including ULK1, ATG13, and ATG101. Through its multiple protein-protein interaction domains, RB1CC1 mediates the organization of focal adhesion complexes and regulates cell motility in response to metabolic stress. Additionally, RB1CC1 participates in selective autophagy pathways, particularly mitophagy and xenophagy, enabling cells to remove damaged mitochondria and intracellular pathogens through autophagy-dependent mechanisms.
The protein's coiled-coil regions facilitate oligomerization and interaction with focal adhesion kinase (FAK), linking mechanical signaling to autophagy regulation. RB1CC1 also interacts with the TSC1-TSC2 complex and mTOR signaling components, connecting nutrient sensing to autophagy control. Its expression is modulated by stress signals including amino acid deprivation, oxidative stress, and proteotoxic conditions that are particularly relevant in neurodegenerative disease contexts.
Role in Neurodegeneration
RB1CC1 dysfunction has been implicated in multiple neurodegenerative conditions through its critical role in protein quality control. In Alzheimer's disease, impaired autophagy flux and reduced RB1CC1 expression compromise the clearance of amyloid-beta aggregates and tau tangles, leading to pathological protein accumulation. Similarly, in Parkinson's disease, defective RB1CC1-mediated autophagy impairs the removal of damaged mitochondria and misfolded alpha-synuclein, exacerbating neuronal vulnerability to oxidative stress.
In ALS (Amyotrophic Lateral Sclerosis), mutations in autophagy-related genes converge on RB1CC1-dependent pathways, with protein aggregates failing to be cleared efficiently. RB1CC1 dysfunction also contributes to Huntington's disease pathology by reducing the clearance of mutant huntingtin protein aggregates. The protein's role in stress-responsive autophagy makes it particularly important in motor neurons, which face high metabolic demands and accumulate proteotoxic stress over time.
Molecular Mechanisms
RB1CC1 mediates neurodegeneration through several interconnected mechanisms. First, as a core ULK1 complex component, RB1CC1 deficiency reduces autophagosome initiation, leading to autophagy flux blockade and substrate accumulation. Second, impaired RB1CC1 function compromises mitophagy, causing dysfunctional mitochondria to persist, increasing ROS production and cellular energy failure. Third, RB1CC1 regulates mTOR signaling; its dysregulation prevents appropriate nutrient sensing, perpetuating mTOR hyperactivation that suppresses autophagy during stress.
Additionally, RB1CC1 coordinates selective autophagy through interactions with autophagy receptors and substrate-binding proteins. Loss of RB1CC1 function disrupts this selectivity, compromising the targeted removal of protein aggregates and damaged organelles. The protein also integrates stress signals through kinase pathways; abnormal RB1CC1 phosphorylation status impairs appropriate autophagy responses to proteotoxic challenges.
Clinical/Research Significance
RB1CC1 represents a convergence point for autophagy dysfunction across multiple neurodegenerative diseases. Research has identified that RB1CC1 expression decreases in neuronal tissues affected by Alzheimer's and Parkinson's diseases, correlating with pathological burden. Pharmacological enhancement of RB1CC1 function or ULK1 complex assembly shows therapeutic promise in preclinical models of neurodegeneration.
Understanding RB1CC1 biology informs therapeutic strategies targeting autophagy enhancement, including direct ULK1 activators and small molecules promoting RB1CC1-ULK1 interactions. Clinical monitoring of RB1CC1 expression levels may provide biomarkers for autophagy dysfunction in neurodegenerative disease progression.